Seeking Alpha

Medtronic's (MDT) business for neuromodulation devices received an FDA warning letter related...

Medtronic's (MDT) business for neuromodulation devices received an FDA warning letter related mainly to the company's processes for handling complaints, MDT CFO Gary Ellis disclosed in a conference call, adding that he does not expect a material impact on financial results. (earlier: FQ1 results)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|